Page last updated: 2024-08-16

thalidomide and hydroxychloroquine

thalidomide has been researched along with hydroxychloroquine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's3 (27.27)29.6817
2010's4 (36.36)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
McCune, WJ; Singer, NG1
Ayoub, N; Barete, S; Francès, C; Piette, JC1
Deng, YJ; Hao, F; Liu, RQ; Sun, RS; Wang, JW; Xiang, MM; Ye, QY; Zhong, BY; Zhou, CL1
Beylot-Barry, M; Doutre, MS; Pham-Ledard, A; Vergier, B1
Bayliss, SJ; Berk, DR; Lu, D; Miller, A; Scarlett, D; Wippold, FJ1
Garza-Mayers, AC; McClurkin, M; Smith, GP1
Tran, B; Wu, J; Yazdani Abyaneh, MA1
Chen, PH; Huang, KP; Lin, CH; Lin, CY; Ni, YL; Tung, HH1
He, J; Liu, T; Xiao, X; Zhou, W1

Reviews

3 review(s) available for thalidomide and hydroxychloroquine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Update on immunosuppressive therapy.
    Current opinion in rheumatology, 1998, Volume: 10, Issue:3

    Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide

1998
Review of treatment for discoid lupus erythematosus.
    Dermatologic therapy, 2016, Volume: 29, Issue:4

    Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide

2016

Other Studies

8 other study(ies) available for thalidomide and hydroxychloroquine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
[Classification of dermatologic manifestations in lupus erythematosus].
    Annales de medecine interne, 2003, Volume: 154, Issue:1

    Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infant, Newborn; Isotretinoin; Keratolytic Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Skin; Sulfasalazine; Thalidomide; Thrombosis; Ultraviolet Therapy; Vasculitis

2003
Generalized eruptive histiocytosis: a possible therapeutic cure?
    The British journal of dermatology, 2004, Volume: 150, Issue:1

    Topics: Adult; Dermatologic Agents; Drug Therapy, Combination; Facial Dermatoses; Histiocytosis, Langerhans-Cell; Humans; Hydroxychloroquine; Male; Prednisone; Thalidomide

2004
Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.
    Dermatology (Basel, Switzerland), 2010, Volume: 220, Issue:2

    Topics: Adolescent; B-Lymphocytes; CD3 Complex; Cyclins; DNA-Binding Proteins; Female; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Neprilysin; Proto-Oncogene Proteins c-bcl-6; Pseudolymphoma; Skin Neoplasms; T-Lymphocytes; Thalidomide; Vaccination

2010
Osseous metaplasia late in the course of nephrogenic systemic fibrosis.
    Dermatology online journal, 2010, Aug-15, Volume: 16, Issue:8

    Topics: Adult; Analgesics; Calcinosis; Disease Progression; Female; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Metaplasia; Nephrogenic Fibrosing Dermopathy; Pregabalin; Quinacrine; Skin; Thalidomide; Treatment Outcome

2010
Rapid response to treatment with thalidomide in an adolescent with generalized discoid lupus erythematosus.
    Pediatric dermatology, 2020, Volume: 37, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Male; Thalidomide

2020
A case report of secondary synchronous diagnosis of multiple myeloma and systemic lupus erythematosus after breast cancer treatment: A CARE-compliant article.
    Medicine, 2022, Sep-02, Volume: 101, Issue:35

    Topics: Aged; Antibodies, Monoclonal; Breast Neoplasms; Female; Glycoproteins; Humans; Hydrocortisone; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Multiple Myeloma; Thalidomide

2022
Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
    Medicine, 2022, Oct-21, Volume: 101, Issue:42

    Topics: Adult; Behcet Syndrome; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Interleukin-2; Methylprednisolone; Oral Ulcer; Thalidomide

2022